Pfizer plans to move a once-a-day version of its weight-loss pill danuglipron into clinical trials [mYaym9YMO]

Pfizer plans to move a once-a-day version of its weight-loss pill danuglipron into clinical trials [mYaym9YMO]

Pfizer announced on Thursday that it plans to begin clinical trials later this year for a reworked, once-daily version of its weight-loss pill, danuglipron, following the discontinuation of a twice-daily version late last year. This new drug is part of a second generation of weight-loss pills being developed by companies such as Eli Lilly and Novo Nordisk, aiming to provide patients with a more convenient alternative to injections. Analysts predict that the weight-loss drug market, currently led by Novo Nordisk's Wegovy and Eli Lilly's Zepbound, could exceed $150 billion in annual sales by the early 2030s. Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision

Related Videos :

• Soup Diet To Lose Weight | Lose 5 Kgs In 3 Days [q6SNdDOZU]
• Trying Brazil Nut for the First Time #shorts #ytshorts #dubai #shorts30 [mLrvPa4FT]
• Weight Loss Exercises | Belly Fat Exercises | Exercises | #shorts #bellyfatloss #exercise #fitness [tUv71lGeT]
• Can #fertility improve with weight loss? #Obesity #Ozempic | Dr. Dan | Obesity Expert [cGSgs3Tez]
• Are you freaking out-Black Swan #viral #movie #shorts #natalieportman #milakunis #vincentcassel [YLc3guSPn]